Aerie Pharmaceuticals

About:

Aerie Pharmaceuticals is a clinical-stage pharmaceutical company developing products for the treatment of glaucoma.

Website: http://www.aeriepharma.com

Twitter/X: aeriepharma

Top Investors: Deerfield, Sofinnova Investments, Alta Partners, OUP (Osage University Partners), Deerfield Capital Management

Description:

Aerie Pharmaceuticals is a biotechnology company that engages in the discovery, development, and commercialization of pharmaceutical products for the treatment of ophthalmic diseases. The company was founded in 2005 and is headquartered in Bridgewater, New Jersey with research facilities in Research Triangle Park, North Carolina. Aerie Pharmaceuticals, Inc. is a former subsidiary of Duke University Medical Center.